This webinar has applied to CAMPEP for approval of 1 MPCEC hour and approved by ASRT for 1 Category A CE credit.
This webinar will present recent pooled data from men treated with stereotactic body radiotherapy (SBRT) for prostate cancer, with follow‑up extending beyond 10 years. Using these long‑term outcomes, the session will review the current evidence base and clinical position of SBRT in the management of prostate cancer.
The presentation will highlight the excellent oncological outcomes and low toxicity profile associated with SBRT. Particular focus will be given to PSA kinetics following SBRT, an area where interpretation remains challenging. Drawing on long‑term institutional data and findings from other key studies, the session will examine the relationship between PSA patterns, biochemical relapse, and clinical recurrence.
The webinar will also explore the expanding role of SBRT in oligometastatic prostate cancer, with discussion centred on the use of SBRT to treat metastatic lesions as a strategy to improve disease control.
By the end of this webinar, participants will be able to:
- Understand the role of SBRT in prostate cancer, including long‑term outcomes and toxicity profiles
- Interpret PSA kinetics following SBRT and their association with biochemical and clinical recurrence
- Explore the emerging role of SBRT in oligometastatic prostate cancer, including treatment of metastatic disease
Presenter: Ah Ram Chang, M.D., Ph.D., Department of Radiation Oncology, Soonchunhyang University, Seoul, South Korea
Professor Ah Ram Chang, M.D., Ph.D. is a Full Professor of Radiation Oncology at Soonchunhyang University, Seoul, South Korea. She received her medical degree from Yonsei University, followed by an MS and Ph.D. from Seoul National University, and completed her residency in Radiation Oncology at Seoul National University Hospital. She has also undertaken international training as a visiting resident at MD Anderson Cancer Center and as a visiting scholar at UCSF Medical Center.
Professor Chang has extensive clinical and academic expertise in stereotactic body radiotherapy (SBRT) and radiosurgery, with a particular focus on prostate cancer, metastatic disease, and re‑irradiation. Her research interests include image‑guided radiotherapy, CyberKnife®‑based SBRT, and the abscopal effects of SBRT, and she has published widely in these areas.
She holds multiple leadership roles within national professional societies, including serving as Division Leader of Radiosurgery and Division Leader of Urologic Oncology within the Korean Radiation Oncology Group, and as Director of Policy for the Korean Radiosurgery Society. Through her clinical practice, research, and leadership, Professor Chang is actively involved in advancing the role of SBRT in both localized and oligometastatic prostate cancer.
Moderator: Sean P. Collins, M.D., Ph.D., University of South Florida, Florida, USA